Records containing: Melanoma (Skin)
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2013-06-20Immunization of Patients With Metastatic Melanoma Using Immunodominant Peptides From the Tyrosinase Protein or Tyrosinase Related Protein-1 (TRP1)
-
CLINICAL_TRIALS study record update · 2013-06-20An Open-label Study Of MDX-010 In Combination With gp100 Peptides Emulsified With Montanide ISA 51 In The Treatment Of Patients With Stage IV Melanoma
-
CLINICAL_TRIALS study record update · 2013-06-20Immunization of Patients With Metastatic Melanoma Using MART-1 and GP100 Peptides Modified to Increase Binding to HLA-0201
-
CLINICAL_TRIALS study record update · 2013-06-20Immunization of Patients With Metastatic Melanoma Using a Recombinant Fowlpox Virus Encoding a GP100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal Sequence
-
CLINICAL_TRIALS study record update · 2013-06-20Phase II Evaluation of Denileukin Diftitox in Patients With Metastatic Melanoma or Metastatic Kidney Cancer
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2013-06-20Treatment of Patients With Metastatic Melanoma Using Cloned Peripheral Blood Lymphocytes Sensitized In Vitro to the gp209-2M Immunodominant Peptide
-
CLINICAL_TRIALS study record update · 2013-06-20Vaccine Therapy With Tumor Specific Mutated Ras Peptides and IL-2 or GM-CSF for Adult Patients With Solid Tumors
-
CLINICAL_TRIALS study record update · 2013-06-20Immunization of Patients With Metastatic Melanoma Using Recombinant Fowlpox and Vaccinia Viruses Encoding the Tyrosinase Antigen
-
CLINICAL_TRIALS study record update · 2013-06-20Skin Self-Examination for Early Detection of Melanoma: Intervention and Consequence
-
CLINICAL_TRIALS study record update · 2013-06-20MDX-CTLA4 Combined With IL-2 for Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2013-06-19A Prospective Random Assignment Trial Comparing Complete Metastasectomy to Chemotherapy for Selected Patients With Stage IV Melanoma
-
CLINICAL_TRIALS study record update · 2013-06-19Immunization of Patients With Metastatic Melanoma Using a Class II Restricted Peptide From the GP100 Antigen and Class I Restricted Peptides From the GP100 and MART-1 Antigens
-
CLINICAL_TRIALS study record update · 2013-06-19A Phase I/II Study of Temozolamide and Thalidomide in the Treatment of Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2013-06-19Use Of Isotretinion For Prevention Of Skin Cancer In Patients With Xeroderma Pigmentosum Or Nevoid Basal Cell Carcinoma Syndrome
-
CLINICAL_TRIALS study record update · 2013-06-19Immunization Of Patients With Metastatic Melanoma Using A Recombinant GP100 Protein (184V) And A Class I Restricted Peptide From The GP100 Antigen
-
CLINICAL_TRIALS study record update · 2013-06-19Treatment Of Patients With Metastatic Melanoma Using Nonmyeloablative But Lymphocyte Depleting Regimen Followed By The Administration Of In Vitro Sensitized Lymphocytes Reactive With ESO-1 Antigen
-
CLINICAL_TRIALS study record update · 2013-06-19Treatment Of Patients With Metastatic Melanoma Using Recombinant Vaccinia And Fowlpox Viruses Encoding The Tyrosine Antigen In Combination With Interleukin-2
-
CLINICAL_TRIALS study record update · 2013-06-19Immunization of HLA-A*0201 Patients With Metastatic Cancer Using a Peptide Epitope From the Telomerase Antigen
-
CLINICAL_TRIALS study record update · 2013-06-19Immunization Of HLA-A*0201 or HLA-DPB1*04 Patients With Metastatic Melanoma Using Epitopes From The ESO-1 Antigen
-
CLINICAL_TRIALS study record update · 2013-06-19Immunization of HLA-0201 Positive Patients With Metastatic Melanoma Using a Peptide From Tyrosinase-related Protein 2 (TRP-2)
-
CLINICAL_TRIALS study record update · 2013-06-19Vaccination of Melanoma Patients With Tyrosinase YMD and gp100 IMD-Javelin Fusion Peptides/HSP70 Complexes: A Trial Comparing the Immunogenicity of Three Doses
-
CLINICAL_TRIALS study record update · 2013-06-19Randomized Comparison of Three Schedules of Peptide Immunization in Patients With Stage II or III, or Completely Resected Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2013-06-06Phase I Trial of Immunotherapy With Adenovirus-Interferon- Gamma (TG1041) in Patients With Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2013-06-05A Phase II Study of Temozolomide (Temodar) and Peglated Interferon Alfa-2B (PEGIntron) in the Treatment of Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2013-05-30A Multicenter Phase II Trial of MGI-114 in Patients With Stage IV Malignant Melanoma